Global Locator
Genzyme Websites
Health Care Professionals
Company
Products
Research
Patients
Responsibility
Careers
News
About Genzyme
Company Leadership
Business Units
News
Press Contacts
Subscribe to News
Recognition and Awards
Working With Genzyme
Global Reach
Download Genzyme Materials
Today is September 20, 2024. All times in Eastern Daylight Time.
Effect of Genzyme’s LEMTRADA™ Maintained in Patients Beyond Two-Year Pivotal MS Studies
03/21/2013 - 03:00 PM
Genzyme’s Multiple Sclerosis Franchise Featured at AAN
03/13/2013 - 02:00 AM
Genzyme’s Head of Rare Diseases Honored by the Genetic Disease Foundation
03/04/2013 - 08:30 AM
Genzyme Recognizes International Rare Disease Day with Global Awareness Programs and Launch of Third Annual Patient Advocacy Leadership (PAL) Awards
02/28/2013 - 01:30 AM
Genzyme Receives Company Award from European Organisation for Rare Diseases (EURORDIS)
02/27/2013 - 05:30 AM
Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease
02/15/2013 - 11:15 AM
Genzyme and Isis Announce FDA Approval of KYNAMRO™ (mipomersen sodium) Injection for the Treatment of Homozygous Familial Hypercholesterolemia
01/29/2013 - 06:30 PM
Genzyme’s LEMTRADA™ (alemtuzumab) Application for MS Accepted for Review by the FDA
01/28/2013 - 01:00 AM
Genzyme and Isis Provide Update on CHMP Opinion on KYNAMRO™ (mipomersen)
12/14/2012 - 07:30 AM
Genzyme Receives European Label Expansion for Thyrogen
12/07/2012 - 07:00 AM
Genzyme Honors Innovation in Gaucher Disease Research through Its 2012 Gaucher Generation Program Awards
11/26/2012 - 09:29 AM
Genzyme’s Once-Daily, Oral AUBAGIO® Approved in Australia for Treatment of Relapsing Multiple Sclerosis
11/21/2012 - 04:00 PM
Genzyme Announces Return to Full Supply of Thyrogen (thyrotropin alfa for injection)
11/13/2012 - 08:00 AM
Sanofi and Genzyme Congratulate the 2012 Schwartz Center Compassionate Caregiver Award Winner
11/09/2012 - 09:00 AM
Genzyme Announces Publication of LEMTRADATM (alemtuzumab) Pivotal Studies in The Lancet
10/31/2012 - 06:30 PM
Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia
10/22/2012 - 06:00 AM
FDA Advisory Committee Recommends KYNAMRO™ for Homozygous Familial Hypercholesterolemia
10/18/2012 - 05:25 PM
Genzyme Presents Second Phase III Study of Once-daily Oral AUBAGIO® (teriflunomide) Confirming Significant Impact on Disability
10/12/2012 - 09:10 AM
Genzyme to Present New Data from AUBAGIO® and LEMTRADATM Clinical Development Programs at ECTRIMS
10/09/2012 - 01:00 AM
Genzyme Phase 3 Study of Oral Compound Eliglustat Tartrate for Gaucher Disease Meets Primary Endpoint
10/02/2012 - 01:00 AM
Genzyme Announces Winners of Patient Advocacy Leadership Awards
10/01/2012 - 08:00 AM
Scientists Rank Genzyme Among Best Employers
09/25/2012 - 09:01 AM
Genzyme Convenes 4th Annual Gaucher Leadership Forum in Munich
09/20/2012 - 09:00 AM
FDA Approves Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis
09/12/2012 - 09:00 PM
Genzyme Provides Update on U.S. LEMTRADA™ Filing
08/27/2012 - 01:00 AM
1
2
3
4
5
6
7
8
9
10
11
12
« Previous
Next »
infoBox
LinkedIn
Yahoo! Buzz
Facebook
Twitter
Delicious
DIGG